6MAY - 2021TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comSeveral developments occurring from within and outside the pharmaceutical industry converge to promote a favourable business climate for progressive CMO firms that align their corporate strategies to take advantage of the signs and signals occurring around them. With the rise in the outsourcing strategy of pharma companies, CMOs have now become increasingly popular. Life sciences companies need CMOs due to the potential increase in the number of products going through preclinical and clinical development and are relying on contract manufacturing to execute their unique requirements while cutting costs. Further, COVID-19 has accelerated the CMO trend as pharma giants are leaving no stones unturned to find a cure to this highly contagious virus. The CMO/CDMO solution sector is uniquely positioned to address some of the challenges that drug developers face amid the COVID-19 pandemic. To ensure growth, CMOs need to capitalize on their increased relevance to make their relationships with pharma companies more strategic. They need to scope and understand the challenges COVID-19 has brought on the supply chain and manufacturing of pharma companies and develop differentiating capabilities to fill these gaps. For instance, different geographical regions are mandating local CMOs to eliminate supply chain bottlenecks due to COVID-19 lockdowns. While pharma companies refocus their core strengths and assets, CDMOs play a crucial role in providing added facilities to mitigate the risk of supply shortages by supplying multisite strategies and backup capacities. Further, firms are increasingly outsourcing regulatory compliance responsibilities to CMO partners to take the load off their shoulders.In this edition of Pharma Tech Outlook, we bring you the story of some of the most successful CMOs in APAC that deliver the best outcomes for their clients. These companies are transforming the CMO landscape with various disruptive technologies and best-in-class solutions. The magazine comprises insights from subject-matter experts, CIOs, and CXOs.Let us know your thoughts.Delivering Value-added Solutions to Pharma CompaniesTECH OUTLOOKTECH OUTLOOKCopyright © 2021 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.MAY - 17 - 2021, Vol 07 - Issue 05 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerJaxon JaseEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:David Parker
< Page 5 | Page 7 >